Neutralizing SARS-CoV-2.
Elife. 2020 12 15; 9E

Abstract

Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies.

Links

Authors+Show Affiliations

Division of Infectious Diseases, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, United States.

MeSH

Antibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesEvolution, MolecularHumansMutationRNA, MessengerSARS-CoV-2Spike Glycoprotein, Coronavirus

Pub Type(s)

Journal Article

Language

eng

PubMed ID

33320086

Citation

Poeschla, Eric. "Neutralizing SARS-CoV-2." ELife, vol. 9, 2020.

Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020;9.

Poeschla, E. (2020). Neutralizing SARS-CoV-2. ELife, 9. https://doi.org/10.7554/eLife.64496

Poeschla E. Neutralizing SARS-CoV-2. Elife. 2020 12 15;9 PubMed PMID: 33320086.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Neutralizing SARS-CoV-2. A1 - Poeschla,Eric, Y1 - 2020/12/15/ PY - 2020/12/11/received PY - 2020/12/11/accepted PY - 2020/12/15/entrez PY - 2020/12/16/pubmed PY - 2020/12/29/medline KW - COVID-19 KW - SARS-CoV-2 KW - VSV KW - antibody KW - immunology KW - infectious disease KW - inflammation KW - microbiology KW - virus KW - viruses JF - eLife JO - Elife VL - 9 N2 - Experiments with hybrid viruses are illuminating how SARS-CoV-2 can escape neutralizing antibodies. SN - 2050-084X UR - https://www.unboundmedicine.com/medline/citation/33320086/Neutralizing_SARS_CoV_2_ DB - PRIME DP - Unbound Medicine ER -

Tags

Neutralizing SARS-CoV-2.Elife. 2020 12 15; 9E